Exploring BLENREP belantamab mafodotinblmf Injection for Cancer Treatment
27/02/2024 Hospitals, Clinics
Price: Check with seller
Description
Belantamab Mafodotin-BLMF injection represents a groundbreaking advancement in the management of multiple myeloma. Belantamab Mafodotin Injection works by targeting a specific protein known as B-cell maturation antigen (BCMA), which is overexpressed on the surface of myeloma cells. By delivering a cytotoxic payload directly to these cells, the injection selectively kill cancerous plasma cells while sparing healthy tissues. It exhibits high specificity towards cancer cells, reducing damage to healthy tissues. This therapy offers a targeted approach to treating the disease, potentially improving outcomes for patients.
Comments
IMPOMED
Individual
More Details